Amneal Pharmaceuticals Plans $120 Million Investment, Creating More Than 500 Jobs In Three States
08/08/2012
The company currently employs over 1100 people in the United States. Amneal officials said in the next two years facility enlargements and resulting jobs increase will generate an estimated $21 million per year in additional payroll and other benefits to local economies.
The capital investment in its manufacturing plants and other facilities will support the firm's expansion into new products such as high potency medications, controlled substances and softgel capsules; new dosage forms including transdermal patches and injectables; and new therapeutic areas like oncology.
Driving further expansion in the U.S. market, Amneal is committed to spending 15 to 20 percent of annual revenue on research and Development, while the industry norm is 5 to 6 percent.
"This major investment in our U.S. operations will more than double Amneal's production volume and add hundreds of jobs while maintaining our dedication to superior quality in our products as well as throughout our organization," said Chintu Patel, Amneal CEO. "It enables us to significantly diversify our generics portfolio, further expanding the value we provide our customers."
"We clearly understand the value of, and are fully committed to, investing and growing within the market we serve, significantly expanding our number of `Made in the USA' products," said Chirag Patel, Amneal President. "Generic pharmaceuticals ensure the lowest cost of medications to help make healthcare more affordable to all consumers."
Project Announcements
JDSAT Expands Fairfax County, Virginia, Operations
04/25/2024
Trussworks Mid-America Plans Jackson, Missouri, Manufacturing Operations
04/25/2024
Epic Flight Academy Establishes Hebron, Kentucky, Operations
04/25/2024
EPC-Columbia Expands Lebanon, Kentucky, Plastic Injection Molding Operations
04/25/2024
Daisy Brand Plans Boone, Iowa, Production Operations
04/22/2024
Canfor Expands Fulton, Alabama, Production Operations
04/22/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024